Scilex Holding Co (SCLX)

NASDAQ
6.270
+0.250(+4.15%)
After Hours
6.350
+0.080(+1.276%)
- Real-time Data
  • Volume:
    393,856
  • Day's Range:
    5.905 - 6.450
  • 52 wk Range:
    2.870 - 16.900

SCLX Overview

Prev. Close
6.02
Day's Range
5.905-6.45
Revenue
41.81M
Open
6.11
52 wk Range
2.87-16.9
EPS
-0.33
Volume
393,856
Market Cap
918.49M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
655,153
P/E Ratio
-18.58
Beta
0.439
1-Year Change
-38.77%
Shares Outstanding
146,489,207
Next Earnings Date
-
What is your sentiment on Scilex Holding?
or
Market is currently closed. Voting is open during market hours.

Scilex Holding Co Company Profile

Scilex Holding Co Company Profile

Employees
90

Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA, a Phase 3, viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica; SP-103 5.4%, a Phase 2, triple-strength formulation of ZTlido, for the treatment of low back pain; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia in multiple Phase 1 program.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong SellStrong SellStrong Sell
  • why +80%?
    0
    • pump and dump
      1